University of Iowa
491
64
93
302
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
13.8%
68 terminated/withdrawn out of 491 trials
81.6%
-4.9% vs industry average
12%
57 trials in Phase 3/4
51%
153 of 302 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (491)
Perinatal Autism Genetics and Epigenetics Study
Role: lead
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Role: collaborator
A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults
Role: collaborator
LURN: Urinary Urgency Phenotyping Protocol
Role: collaborator
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
Role: lead
Optimized Erythropoietin (EPO) Treatment
Role: lead
Teen Driving Translation Study (NIH)
Role: collaborator
Birth to Three - Cavity Free
Role: lead
Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study
Role: collaborator
Living WELL: A Web-Based Program for Ovarian Cancer Survivors
Role: collaborator
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Role: collaborator
Wearable Bioimpedance Analyzer for Tracking Body Composition Changes
Role: lead
A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers
Role: lead
Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy
Role: collaborator
Carbon Dioxide (CO2) Chemosensitivity and SUDEP
Role: lead
The BrainHealth Project
Role: collaborator
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
Role: collaborator
Cystoealstometer (Bladder Monitor Device)-Home Use
Role: lead
Pharmacokinetics of Transdermal Metronidazole
Role: lead
Oral N-acetylcysteine for Retinitis Pigmentosa
Role: collaborator